Suresh S Ramalingam Selected Research

Suresh S Ramalingam Research Topics

Disease

132	Neoplasms (Cancer) 11/2022 - 06/2007
123	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 06/2007
63	Lung Neoplasms (Lung Cancer) 11/2022 - 11/2010
23	Disease Progression 09/2021 - 11/2008
19	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2020 - 03/2010
8	Adenocarcinoma of Lung 09/2020 - 12/2015
8	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
6	Fatigue 01/2020 - 06/2008
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2021 - 09/2014
5	Neutropenia 05/2021 - 08/2017
5	Adenocarcinoma 01/2020 - 05/2011
5	Carcinogenesis 01/2019 - 03/2012
4	Brain Neoplasms (Brain Tumor) 01/2022 - 02/2012
4	Diarrhea 05/2021 - 08/2010
4	Pneumonia (Pneumonitis) 01/2018 - 12/2016
3	Mesothelioma 11/2021 - 09/2008
3	Malignant Mesothelioma 11/2021 - 09/2008
3	Head and Neck Neoplasms (Head and Neck Cancer) 11/2020 - 06/2007
3	Nausea 01/2020 - 01/2010
3	Epilepsy (Aura) 01/2019 - 04/2017
3	Squamous Cell Carcinoma of Head and Neck 01/2019 - 03/2014
3	Hypertension (High Blood Pressure) 12/2017 - 08/2010
2	Exanthema (Rash) 01/2022 - 11/2014
2	Respiratory Insufficiency (Respiratory Failure) 05/2021 - 12/2016
2	Dyspnea (Shortness of Breath) 05/2021 - 09/2008
2	Necrosis 01/2021 - 04/2013
2	Hyperglycemia 01/2020 - 12/2014
2	Thrombocytopenia (Thrombopenia) 12/2019 - 06/2012
2	Hyponatremia 12/2019 - 01/2010
2	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 09/2017

Drug/Important Bio-Agent (IBA)

37	ErbB Receptors (EGF Receptor)IBA 10/2021 - 01/2008
36	osimertinibIBA 06/2022 - 04/2015
25	Tyrosine Kinase InhibitorsIBA 01/2022 - 05/2008
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2010
18	Biomarkers (Surrogate Marker)IBA 11/2021 - 06/2012
16	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 06/2007
16	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 06/2007
13	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 09/2008
11	B7-H1 AntigenIBA 01/2022 - 01/2018
11	PlatinumIBA 12/2021 - 01/2008
11	Everolimus FDA Link 10/2020 - 08/2010
11	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 12/2008
9	Immune Checkpoint InhibitorsIBA 01/2022 - 03/2015
9	NivolumabIBA 01/2022 - 03/2015
9	Pharmaceutical PreparationsIBA 01/2020 - 01/2008
8	LigandsIBA 01/2022 - 08/2011
7	veliparibIBA 11/2021 - 12/2014
7	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2008
7	Etoposide (VP 16)FDA LinkGeneric 10/2020 - 01/2014
7	Docetaxel (Taxotere)FDA Link 01/2020 - 11/2008
7	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 12/2012
7	Monoclonal AntibodiesIBA 01/2019 - 05/2008
7	TOR Serine-Threonine KinasesIBA 01/2019 - 12/2008
7	Anaplastic Lymphoma KinaseIBA 03/2016 - 04/2012
6	Biological ProductsIBA 01/2022 - 03/2009
6	IpilimumabIBA 01/2022 - 05/2018
6	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2007
5	Pemetrexed (MTA)FDA Link 11/2021 - 09/2008
5	MTOR InhibitorsIBA 02/2021 - 12/2008
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020 - 03/2010
5	Phosphotransferases (Kinase)IBA 12/2019 - 02/2012
5	Sirolimus (Rapamycin)FDA Link 01/2019 - 12/2008
5	Cetuximab (Erbitux)FDA Link 07/2015 - 11/2008
5	Vorinostat FDA Link 10/2010 - 06/2007
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2019
4	pembrolizumabIBA 01/2022 - 02/2018
4	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2013
3	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 11/2022 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 04/2017
3	AntigensIBA 01/2022 - 06/2012
3	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2015
3	AntibodiesIBA 01/2021 - 01/2016
3	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020 - 01/2015
3	Cytotoxins (Cytolysins)IBA 12/2019 - 01/2013
3	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 11/2008
3	human ERBB2 proteinIBA 11/2017 - 03/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 03/2009
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2015 - 03/2011
3	Histone Deacetylases (Histone Deacetylase)IBA 03/2014 - 09/2008
3	Eukaryotic Initiation Factor-4EIBA 03/2013 - 08/2009
2	durvalumabIBA 11/2021 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2021 - 01/2020
2	sotorasibIBA 01/2021 - 01/2020
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2021 - 08/2011
2	NVP-BKM120IBA 01/2020 - 12/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 12/2008
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2019 - 12/2014
2	Gefitinib (Iressa)FDA Link 01/2019 - 01/2019
2	TensinsIBA 01/2018 - 10/2017
2	Adenosine Monophosphate (AMP)IBA 01/2018 - 11/2014
2	RamucirumabIBA 01/2018 - 04/2016

Therapy/Procedure

84	Therapeutics 10/2021 - 01/2008
36	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
21	Immunotherapy 05/2022 - 01/2015
12	Radiotherapy 11/2019 - 03/2011
4	Precision Medicine 01/2022 - 03/2014
3	Adjuvant Chemotherapy 01/2022 - 03/2016
2	Chemoprevention 11/2020 - 03/2014
2	Salvage Therapy 01/2020 - 03/2013
2	Chemoradiotherapy 01/2019 - 09/2017